Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Amelia Szymanowska-Narloch"'
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic disease of the lungs which is characterized by heavy symptom burden, especially in the last year of life. Despite recently established anti-fibrotic treatment IPF prognosis is one of the w
Externí odkaz:
https://doaj.org/article/3701438ef5d04b65b221457cca370062
Publikováno v:
Rheumatology Forum. 8:77-83
Publikováno v:
Advances in Respiratory Medicine. 87:244-253
This is a review considering atypical manifestations of granulomatosis with polyangiitis (GPA). Virtually any organ can be affected, and in some patients, GPA can manifest unusually. Since thoracic involvement of GPA often predominates, the first who
Publikováno v:
Contemporary Oncology, Vol 21, Iss 3, Pp 254-258 (2017)
Contemporary Oncology
Contemporary Oncology
Non-small cell lung cancer (NSCLC) driven by activating mutations in epidermal growth factor receptor (EGFR) constitutes up to 10% of NSCLC cases. According to the NCCN recommendations, all patients (with the exception of smoking patients with squamo
Autor:
Jacek Jassem, Anna Papiez, Ryszard Pawłowski, Agnieszka Maciejewska, Amelia Szymanowska-Narloch, Ewa Jassem, Witold Rzyman, Joanna Polanska, Marcin Skrzypski, Rafal Dziadziuszko
Publikováno v:
Practical Applications of Computational Biology and Bioinformatics, 12th International Conference ISBN: 9783319987019
PACBB
PACBB
This article describes the use of a comprehensive approach for the identification of differentiating gene related blocks of SNPs based on Fisher’s p-value integration with a pooled correlation approximation. This pre-selection step is proposed as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32a7181fd7bbdd327b6bd053007b176c
https://doi.org/10.1007/978-3-319-98702-6_15
https://doi.org/10.1007/978-3-319-98702-6_15
Autor:
Lenka Šišková, Veronika Müller, Jana Psikalova, Vladimíra Lošťáková, Robert Slivka, Michal Svoboda, Anikó Bohács, Miklós Zsiray, Jan Kus, Jan Anton, Ladislav Lacina, Jaroslav Lněnička, Mária Szilasi, Marzena Trzaska-Sobczak, Margita Bučeková, Robert Vyšehradský, Peter Paluch, Zoltán Balikó, Imrich Jonner, Katarzyna Lewandowska, Daniel Doležal, Renata Králová, Martina Doubková, Vladimir Bartos, Richard Tyl, Zsuzsanna Szalai, Imre Lajkó, Amelia Szymanowska-Narloch, Štefan Laššán, Beata Zolnowska, Pawel Sliwinski, Martina Vasakova, Jasna Tekavec-Trkanjec, Marina Roksandic Milenkovic, Bohumil Matula, Małgorzata Sobiecka, Nesrin Mogulkoc, Pavlína Lisá, Marta Hájková, Jana Strenková, Sebastian Majewski, D. Jovanovic, Štefan Tóth, Jiří Homolka, František Petřík, Pavlina Musilova, Tomáš Snížek, Radka Bittenglova, Martina Plačková, Hana Suldova, Ján Plutinský, Monika Žurková, Vladimír Řihák, Jan Kervitzer, Magdalena Martusewicz-Boros, Ilona Binková, Martina Sterclova
Publikováno v:
Diffuse Parenchymal Lung Disease.
Most patients with IPF have comorbidities, which affect functional status, quality of life and survival. Our study aims are to analyze comorbidities in a series of 1210 IPF patients from the EMPIRE registry (European Multipartner IPF registry). Comor
Autor:
Ladislav Lacina, Bučeková Bučeková, Jaroslav Lněnička, Ján Plutinský, František Petřík, Daniel Doležal, Pavlina Musilova, Vladimír Řihák, Jana Psikalova, Pavlína Lisá, Ilona Binková, Štefan Laššán, Vladimíra Lošťáková, Martina Sterclova, Veronika Müller, Imrich Jonner, Małgorzata Sobiecka, Miklós Zsiray, Jan Kervitzer, Martina Plačková, Radka Bittenglova, Štefan Tóth, Magdalena Martusewicz-Boros, Robert Vyšehradský, Jasna Tekavec-Trkanje, Zoltán Balikó, Dragana Jovanovic, Nesrin Mogulkoc, Jan Kus, Marzena Trzaska-Sobczak, Monika Žurková, Pawel Sliwinski, Katarzyna Lewandowska, Robert Slivka, Michal Svoboda, Anikó Bohács, Vladimir Bartos, Jiří Homolka, Jan Anton, Lenka Šišková, Sebastian Majewski, Marta Hájková, Beata Zolnowska, Martina Vasakova, Marina Roksandic Milenkovic, Amelia Szymanowska-Narloch, Tomáš Snížek, Imre Lajkó, Jana Strenková, Peter Paluch, Renata Králová, Bohumil Matula, Richard Tyl, Martina Doubková, Mária Szilasi, Hana Suldova, Zsuzsanna Szalai
Publikováno v:
Diffuse Parenchymal Lung Disease.
Key feature of IPF is decline in forced vital capacity (FVC) and CO diffusion (DLco), but data on clinical determinants of this change in patients who have established disease are scarce. For a given patient it is unknown if different natural histori
Autor:
Katarzyna Lewandowska, Małgorzata Sobiecka, Magdalena Martusewicz-Boros, Beata Zolnowska, Martina Vasakova, Jan Kus, Sebastain Majewski, Pawel Sliwinski, Jana Strenková, Marzena Trzaska-Sobczak, Amelia Szymanowska-Narloch
Publikováno v:
Diffuse Parenchymal Lung Disease.
Epidemiological data on IPF patients in Poland is scarce. There is no national registry of IPF cases. Facing the possibility of antifibrotic treatment opportunities, knowledge of the demografic and clinical features of IPF patients is crucial. Aim: T
Autor:
Miklós Zsiray, Imrich Jonner, Katarzyna Lewandowska, Peter Paluch, Vladimíra Lošťáková, Štefan Laššán, Jan Kervitzer, Bohumil Matula, Robert Vyšehradský, Małgorzata Sobiecka, Marzena Trzaska-Sobczak, Imre Lajkó, Robert Slivka, Michal Svoboda, Štefan Tóth, Pavlína Lisá, Jan Anton, Anikó Bohács, Magdalena Martusewicz-Boros, Mária Szilasi, Zoltán Balikó, Renata Králová, Richard Tyl, Nesrin Mogulkoc, Ladislav Lacina, Marta Hájková, Jasna Tekavec-Trkanjec, Jan Kus, Beata Zolnowska, Martina Vasakova, Monika Žurková, Margita Bučeková, Martina Doubková, Marina Roksandic Milenkovic, Vladimir Bartos, Daniel Doležal, Martina Sterclova, Jaroslav Lněnička, Jana Psikalova, Pawel Sliwinski, Amelia Szymanowska-Narloch, Zsuzsanna Szalai, Veronika Müller, Jana Strenková, Ján Plutinský, Sebastian Majewski, Lenka Šišková, Dragana Jovanovic, Tomáš Snížek, Radka Bittenglova, Jiří Homolka, František Petřík, Pavlina Musilova, Hana Suldova, Martina Plačková, Vladimír Řihák, Ilona Binková
Publikováno v:
Diffuse Parenchymal Lung Disease.
Aims: Many patients with idiopathic pulmonary fibrosis (IPF) have a delay in diagnosis and thus also in treatment. We investigated whether such delay influenced survival and treatment response to pirfenidone and nitedanib. Methods: The retrospective
Autor:
Thomas Muley, M Jarząb, Michael Meister, Rafael Rosell, Hendrik Dienemann, Ryszard Pawłowski, Witold Rzyman, Ewa Jassem, Miquel Taron, Amelia Szymanowska-Narloch, Robert Rzepko, M. Skrzypski, Tomasz Marjański, Jacek Jassem
Publikováno v:
Advances in Medical Sciences. 58:196-206
Purpose: Molecular features of non-small cell lung cancer (NSCLC) in never-smokers are not well recognized. We assessed the expression of genes potentially related to lung cancer etiology in smoking vs. never-smoking NSCLC patients. Methods: We assay